ArticleBMC obesity2016
Aspiration therapy for obesity; a safe and effective treatment.
Article in BMC obesity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Efficacy of Endoscopic Interventions for the Management of Obesity: a Meta-analysis to Compare Endoscopic Sleeve Gastroplasty, AspireAssist, and Primary Obesity Surgery Endolumenal.Obesity surgery · 2019Pooled it
- Mechanism of action and selection of endoscopic bariatric therapies for treatment of obesity.Clinical endoscopy · 2024Review
- Overview on the endoscopic treatment for obesity: A review.World journal of gastroenterology · 2023Review
- Review
- Conversion of AspireAssist System® to Sleeve Gastrectomy: Technical Video Description.Obesity surgery · 2019Article
- Endoscopic bariatric therapies for treating obesity: a learning curve for gastroenterologists.Translational gastroenterology and hepatology · 2019Review
- Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy.GE Portuguese journal of gastroenterology · 2018Article
- Aspiration Therapy As a Tool to Treat Obesity: 1- to 4-Year Results in a 201-Patient Multi-Center Post-Market European Registry Study.Obesity surgery · 2018Observational
- Endoscopic Medical Devices for Primary Obesity Treatment in Patients With Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2017Article
- Latest Developments and Future Perspectives in the Field Of Obesity.European endocrinology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study evaluated the efficacy and safety of the novel AspireAssist® Aspiration Therapy System for treatment of obesity, and its effect on patient's quality of life.
methodsA prospective observational study with 25 obese subjects, mean age 48 years (range 33-65), was performed. A custom gastrostomy tube (A-tube, Aspire Bariatrics) was percutaneously inserted during a gastroscopy performed under conscious sedation. Drainage and irrigation of the stomach were performed 3 times daily, 20 min after each meal, for 1-2 years. Efficient aspiration required thorough chewing of ingested food. Treatment included a cognitive behavioral weight loss program.
resultsMean body mass index (BMI) at inclusion was 39.8 kg/m
conclusionsAspiration therapy is an efficient and safe treatment for obesity, and weight reduction improves quality of life. Excess weight was approximately halved in a year, with weight stability if treatment was continued.
trial registrationTrial Register ISRCTN 49958132. Retrospectively registered 28/02/2014.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.